Didronel Articles

NICE ordered to publish methodology in osteoporosis drug decision by UK court

2 March 2009

FDA finds no AF link for bisphosphonates

24 November 2008

UK's NICE issues final guidance on osteoporosis prevention

3 November 2008

NOS slams NICE rules on 2nd-line osteo drugs

14 July 2008

FDA warns: severe pain with bisphosphonates

14 January 2008

Many osteoporosis medicines prevent fractures but none is proven best

24 December 2007

UK NICE: preventing secondary osteoporotic fractures in post-menopausal women

31 January 2005

P&G cuts further 9,600 jobs as pharma division comes under spotlight

23 March 2001

Osteoporosis market "to more than triple"

23 November 2000

Schein Pharma and MGI end promotional relationship on INFeD

1 April 1999

First Launch Of Actonel For Paget's

21 October 1998

Risedronate Cleared By FDA For Paget's

8 April 1998

UK Clears Didronel PMO For Prevention

9 June 1997

Alendronate In Fracture Intervention

16 December 1996

Germany Approves P&G's Didronel

15 April 1996

Sandoz Launches Nasal Calcitonin In USA

18 December 1995

Procter & Gamble's Didronel: new study data

25 September 1995

Sandoz' Calcitonin Spray Approved

11 September 1995

Procter & Gamble To Expand Drugs Business

14 August 1995

Canada Approves Procter & Gamble's Didrocal

31 July 1995

Merck's Fosamax Nears Market In USA

24 July 1995

Merck's Fosamax Set For Rapid US Approval?

12 June 1995

The ABPI's A-Z Of British Medicines Research

29 May 1995

Panel Dismisses Etidronate Osteoporosis Claim

28 November 1994

Didrocal To Be Reviewed By FDA

31 October 1994

TILUDRONATE EFFICACY SHOWN

4 April 1994

US BIOTECH AND SMALL DRUG COs STEADY

22 November 1993

ABPI CODE OF PRACTICE LATEST REPORT

21 December 1992

DIDRONEL SAFE FOR LONG-TERM USE

13 January 1992

Showing 1-29 of 29 articles

Go to beginningPrevious
  • 1
NextGo to end